Ga-68 DOTATATE Whole Body PET-CT Scan

22000

Ga-68 DOTATATE Whole Body PET-CT Scan is An medicinal imaging technology used to identify and evaluate neuroendocrine tumors (NETs). It also entails a radiotracer called Gallium-68 DOTATATE that attaches to somatostatin receptors that are over-expressed on neuroendocrine tumor cells.

It is a scan, which combines both PET (functional scanning) and CT (structural scanning) to allow one to measure the presence, spread, and activity of the tumors throughout the entire body in an extremely precise way. It is considered one of the most sensitive and selective imaging technologies to diagnose and treat neuroendocrine tumours.

Procedure of Ga-68 DOTATATE PET-CT

Before the Scan

  • It may be necessary to fast for 4-6 hours.
  • Stay well hydrated
  • Report medications, pregnancy, and medical conditions to the doctor.
  • No heavy physical exercise before the scan.

During the Scan

  • Ga-68 DOTATATE radiotracer is a small dose injected into a vein.
  • Tracer uptake waiting period is about 45-60 min.
  • The scan is on a PET-CT scanner.
  • Imaging requires the patient to lie motionless.
  • Scan time is about 20-40 minutes.

After the Scan

  • Take lots of fluids to get rid of the tracer.
  • Resume normal activities.
  • Radiation exposure is low and short-lived.

Techniques Used

  • PET Imaging: Receptor activity is detected in tumors.
  • CT Imaging: Offers anatomy.
  • Ga-68 DOTATATE Tracer: Somatropin receptors.
  • Whole Body Imaging: Determines illness in the body.

Benefits

  • Very sensitive and specific to neuroendocrine tumors.
  • Early and small lesions are detected.
  • Provides whole-body evaluation.
  • Non-invasive and safe.
  • Assist with direct individual therapy.

Conditions Diagnosed

  • Neuroendocrine tumors (NETs).
  • Carcinoid tumors.
  • Gastroenteropancreatic NETs.
  • Metastatic neuroendocrine disease.
  • Recurrence of tumor or residual tumor.

Risks and Considerations

Radiation Exposure

  • Low-level radiation is considered safe

Pregnancy

  • Not recommended unless necessary

Allergic Reactions

  • Rare, as tracer reactions are uncommon

Physical Activity

  • Excess activity before the scan may affect the results

Comparison with Other Imaging Techniques

  • CT Scan: Anatomical but poor functional information.
  • MRI: Good soft tissue, but no receptor-specific.
  • FDG PET-CT: More appropriate for aggressive tumors and less accurate with NETs.
  • Ga-68 DOTATATE PET-CT: very specific towards tumors with somatostatin receptors.

Clinical Importance

Ga-68 DOTATATE PET-CT would be an important instrument in the contemporary oncology of neuroendocrine tumors:

  • Allows very early and proper detection.
  • Assistance in stage directions and treatment planning.
  • Assesses the suitability for PRRT treatment.
  • Monitors treatment compliance and has recurrence

Its receptor specificity is high, making it an ideal imaging gold standard in most neuroendocrine tumors.

Conclusion

Whole Body PET-CT Scan Ga-68 DOTATATE is a highly developed and trustworthy image modality for assessing neuroendocrine tumors. It gives high specificity in diagnosis and thorough assessment of the disease by utilizing both functional and structural imaging, coupled with receptor targeting.

It is of great importance in early diagnosis, treatment, and follow-up monitoring, which helps greatly in patient outcomes.

Test information: Fasting: 4-6 hours

Reporting: Within 24–48 hours

  • Fasting for 4–6 hours is required (water is allowed)

  • Stay well hydrated before the scan

  • Avoid strenuous physical activity for 24 hours prior

  • Inform your doctor about all medications

  • Inform if you are pregnant or breastfeeding

  • Diabetic patients should consult for specific instructions

  • Remove all metal objects (jewellery, belt, etc.)

* For details, please see service-related policies

Talk to Health Expert

Health Articles
Polycystic Ovary Syndrome vs Polycystic Ovarian Disease: Differences, Symptoms, and Diagnosis
Polycystic Ovary Syndrome vs Polycystic Ovarian D… 📅 29 Apr, 2026 | ✍️ By Molecular Diagnostics and Therapy LLP
Thyroid Imbalance and Weight Gain: What’s the Link?
Thyroid Imbalance and Weight Gain: What’s the Lin… 📅 29 Apr, 2026 | ✍️ By Molecular Diagnostics and Therapy LLP
Urinary Tract Infection: Symptoms and Diagnosis
Urinary Tract Infection: Symptoms and Diagnosis 📅 27 Apr, 2026 | ✍️ By Molecular Diagnostics and Therapy LLP
आर्थराइटिस (Arthritis): प्रकार, लक्षण और ब्लड टेस्ट